Key approvals for Regeneron, Corcept, and a Fast Track designation for Alto Neuroscience signal a positive regulatory environment.
Analyst sets a new $70 price target, citing strong revenue forecasts and potential for margin expansion for the airline carrier.
Shares surge on massive volume after EPS Ventures announced its intention to acquire LNG shipping firm Cool Company.
A flurry of multi-billion dollar acquisitions by Pfizer, Genmab, and Axcelis signals renewed confidence and strategic positioning in high-growth sectors.
Analyst cites a 'stronger for longer' demand cycle for hard disk drives, fueled by the explosive growth of cloud computing and AI.
Analysts cite strong fundraising and execution as key drivers for the alternative asset manager's upgraded rating and bullish outlook.
Irenic Capital reveals a 2% stake, urging the software firm to overhaul its board and explore strategic options after a period of underperformance.
The deal paves the way for the integration of Monogram's advanced surgical robotics, with a closing date set for early October 2025.